Inventor · disambiguated record
Viranga Tillekeratne
Also filed as: TILLEKERATNE VIRANGA
7 granted patents·1 pending application·3 citations·filing 2006–2023
73Inventor score
Top patents by PatentIndex Score
8 records- 0179US9862692B2Highly selective anti-cancer agents targeting non-small cell lung cancer and other forms of cancerUNIV TOLEDO·Filed 2014·Granted Jan 9, 2018·2 cites·2 claims
- 0273US7893268B2Epithiolone analoguesUNIV TOLEDO·Filed 2006·Granted Feb 22, 2011·1 cites·2 claims
- 0361US10392354B2Highly selective anti-cancer agents targeting non-small cell lung cancer and other forms of cancerUNIV TOLEDO·Filed 2018·Granted Aug 27, 2019·0 cites·19 claims
- 0458US10138216B2Highly selective anti-cancer agents targeting non-small cell lung cancer and other forms of cancerUNIV TOLEDO·Filed 2017·Granted Nov 27, 2018·0 cites·9 claims
- 0558US2024109852A1Ferroptosis-HDAC Inhibitor Hybrid Anticancer AgentsUNIV TOLEDO·Filed 2023·Application pending·0 cites
- 0654US11548850B2Development of a cofilin inhibitor for the treatment of hemorrhagic brain injury-induced neuroinflammationUNIV TOLEDO·Filed 2020·Granted Jan 10, 2023·0 cites·16 claims
- 0745US11098038B2Imidazole-based anticancer agents and derivatives thereof, and methods of making and using sameUNIV TOLEDO·Filed 2018·Granted Aug 24, 2021·0 cites·35 claims
- 0841US8435983B2Conformationally restrained epothilone analogues as anti-leukemic agentsTILLEKERATNE VIRANGA·Filed 2008·Granted May 7, 2013·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Viranga Tillekeratne files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →